Waraba Gold Limited completed a quarterly debt settlement by issuing 281,358 common shares worth approximately C$105,691 to settle US$74,378 in management fees owed to directors, officers, and a consultant. The shares were issued at C$0.38 each and are subject to a four-month hold period. The company plans to continue settling future quarterly management fees through share issuance under the same pricing formula, without issuing separate press releases unless material changes occur. Related party transactions involved insiders but were exempt from minority approval due to their size relative to market capitalization. This move helps Waraba reduce liabilities and improve its financial position.
Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...
General Electric (GE) announced it will acquire Consolidated Precision Products (CPP) for $11.75 billion to enhance its aerospace casting production. This strategic move aims to strengthen GE's manufacturing capabilities and accelerate engine technol...
United Natural Foods, Inc. (UNFI) reported a Q4 adjusted EPS of $0.69, surpassing analyst expectations of $0.61, signaling strong profitability. However, revenue slightly missed estimates at $7.64 billion, down 0.7% from the previous year. Despite th...
Ionis Pharmaceuticals faced a setback when its experimental heart drug pelacarsen failed a Phase 3 trial to reduce cardiovascular events, causing an 8.6% stock drop. However, an analyst from Canaccord Genuity maintained a bullish $85 price target, im...
Casey's General Stores will release its Q3 2026 earnings on September 8 after market close, with analysts expecting an EPS of $6.78 and revenue of $5.56 billion. The company has a strong history of exceeding earnings estimates, with an average surpri...
